The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma (Q62818294)

From Wikidata
Jump to navigation Jump to search
scientific article published on 07 November 2006
edit
Language Label Description Also known as
English
The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma
scientific article published on 07 November 2006

    Statements

    title
    The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17089127
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17089127%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    21 December 2019
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q62818294&oldid=1752414930"